- Home
- ADCT vs AIP Comparison
ADCT vs AIP Comparison
Compare ADCT & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- AIP
- Stock Information
- Founded
- ADCT 2011
- AIP 2003
- Country
- ADCT Switzerland
- AIP United States
- Employees
- ADCT N/A
- AIP N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- AIP Semiconductors
- Sector
- ADCT Health Care
- AIP Technology
- Exchange
- ADCT Nasdaq
- AIP Nasdaq
- Market Cap
- ADCT 260.9M
- AIP 288.1M
- IPO Year
- ADCT 2020
- AIP 2021
- Fundamental
- Price
- ADCT $3.14
- AIP $7.29
- Analyst Decision
- ADCT Strong Buy
- AIP Strong Buy
- Analyst Count
- ADCT 5
- AIP 4
- Target Price
- ADCT $8.00
- AIP $13.00
- AVG Volume (30 Days)
- ADCT 400.0K
- AIP 78.9K
- Earning Date
- ADCT 11-05-2024
- AIP 11-05-2024
- Dividend Yield
- ADCT N/A
- AIP N/A
- EPS Growth
- ADCT N/A
- AIP N/A
- EPS
- ADCT N/A
- AIP N/A
- Revenue
- ADCT $66,745,999.00
- AIP $53,300,000.00
- Revenue This Year
- ADCT $6.58
- AIP $7.54
- Revenue Next Year
- ADCT $14.28
- AIP $19.47
- P/E Ratio
- ADCT N/A
- AIP N/A
- Revenue Growth
- ADCT N/A
- AIP 3.12
- 52 Week Low
- ADCT $0.36
- AIP $4.20
- 52 Week High
- ADCT $6.04
- AIP $9.54
- Technical
- Relative Strength Index (RSI)
- ADCT 52.52
- AIP 47.41
- Support Level
- ADCT $2.93
- AIP $7.26
- Resistance Level
- ADCT $3.11
- AIP $7.66
- Average True Range (ATR)
- ADCT 0.21
- AIP 0.30
- MACD
- ADCT 0.00
- AIP 0.02
- Stochastic Oscillator
- ADCT 58.67
- AIP 47.83
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
About AIP Arteris Inc.
Arteris Inc is a developer of on-chip interconnect fabric technology designed for a variety of devices and in the development and distribution of Network-on-Chip (NoC) interconnect intellectual property (IP). The company's technology is used in System-on-Chip (SoC) and provides software and services to automate SoC integration, enabling users to efficiently deploy NoC IP, and offer IP support, maintenance services, professional services, and training and on-site support services. The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.